In HCC, elevated FABP2 serum concentrations were observed in patients compared to healthy controls, suggesting increased intestinal permeability or enterocyte injury in the setting of chronic liver disease [83]. This evidence concerns the gene FABP2 and hepatocellular carcinoma.